APA

Vij R., DiPersio J. F., Venkatraman P., Trinkaus K., Goodnough L. T., Brown R. A., Khoury H. J., Devine S. M., Oza A., Shenoy S., Blum W. & Adkins D. (20030401). Donor CMV serostatus has no impact on CMV viremia or disease when prophylactic granulocyte transfusions are given following allogeneic peripheral blood stem cell transplantation. : Blood.

Chicago

Vij Ravi, DiPersio John F, Venkatraman Partha, Trinkaus Kathryn, Goodnough Lawrence T, Brown Randy A, Khoury Hanna J, Devine Steven M, Oza Aarti, Shenoy Shalini, Blum William and Adkins Douglas. 20030401. Donor CMV serostatus has no impact on CMV viremia or disease when prophylactic granulocyte transfusions are given following allogeneic peripheral blood stem cell transplantation. : Blood.

Harvard

Vij R., DiPersio J. F., Venkatraman P., Trinkaus K., Goodnough L. T., Brown R. A., Khoury H. J., Devine S. M., Oza A., Shenoy S., Blum W. and Adkins D. (20030401). Donor CMV serostatus has no impact on CMV viremia or disease when prophylactic granulocyte transfusions are given following allogeneic peripheral blood stem cell transplantation. : Blood.

MLA

Vij Ravi, DiPersio John F, Venkatraman Partha, Trinkaus Kathryn, Goodnough Lawrence T, Brown Randy A, Khoury Hanna J, Devine Steven M, Oza Aarti, Shenoy Shalini, Blum William and Adkins Douglas. Donor CMV serostatus has no impact on CMV viremia or disease when prophylactic granulocyte transfusions are given following allogeneic peripheral blood stem cell transplantation. : Blood. 20030401.